Fenwal Controls of Japan, Ltd.

6870.T
Security & Protection Services
2026/10/30 18:57 Updated
Market Cap: $68.7M (¥10.9B)
Stock Price: $12.25 (¥1,935)
Exchange Rate: 1 USD = ¥157.98

Fenwal Controls of Japan, Ltd. Financial Summary for the Third Quarter of the Fiscal Year Ending December 2026 (Japanese GAAP, Consolidated)

For the third quarter of the fiscal year ending December 2026, consolidated results were: net sales of 9,943 million yen (Year-over-Year +6.9%), operating income of 1,094 million yen (YoY +15.8%), ordinary income of 1,168 million yen (YoY +23.7%), and quarterly net income attributable to owners of parent of 687 million yen (YoY -32.2%). By segment, the Thermal segment remained strong due to expanding semiconductor demand. Conversely, the Medical segment declined significantly due to the termination of contract manufacturing. The full-year forecast remains unchanged.

Importance:
Page Updated: October 30, 2026
IR Disclosure Date: October 30, 2026

Key Figures

  • Net Sales: 9,943 million yen (YoY +6.9%)
  • Operating Income: 1,094 million yen (YoY +15.8%)
  • Quarterly Net Income Attributable to Owners of Parent: 687 million yen (YoY -32.2%)

AI要約

Overview of Performance

In the third quarter of the fiscal year ending December 2026, consolidated net sales increased 6.9% year-over-year to 9,943 million yen. By segment, the Thermal segment contributed significantly due to a substantial rise in orders and shipments driven by expanding semiconductor demand. Meanwhile, the Medical segment saw a sharp decline due to the termination of contract manufacturing, resulting in a 32.2% year-over-year decrease in consolidated net income. From a financial perspective, both operating income and ordinary income showed growth compared with the prior year.

Outlook and Impact

The full-year forecast remains unchanged from the previously announced outlook, but the effects of matters such as the revocation of certification for gas fire suppression equipment containers continue to be examined. Demand for the Thermal segment is expected to continue due to increased investment in the semiconductor market, and the company will continue to pursue orders with an emphasis on profitability. As the Medical segment wind-down progresses, the company plans to drive growth through other segments.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Fenwal Controls of Japan, Ltd.

Company overview · Stock price · Financial data · All IR

View company page →